Zhihua Ma

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Baicheng Ma2
Minggang Li2
Kunyan Qiao2
Yaofang Zhang2
2Baicheng Ma
2Minggang Li
2Kunyan Qiao
2Yaofang Zhang
Learn More
Glucagon-like peptide-1 (GLP-1) reduces blood glucose and improves abnormal metabolism caused by hyperglycemia. The formation of thrombus, one of major consequences suffered from diabetes, can be inhibited by the treatment of Hirudin (HV). This study was aimed to develop a fusion peptide which combines functions of GLP-1 and HV to treat diabetes and its(More)
Glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) have a similar but complementary role in regulating blood glucose level. This study was aimed to develop a functional-complementary dual insulinotropic peptide which releases both GLP-1 and GIP in vivo, and to investigate its therapeutic effect on type 2 diabetes in mice. We firstly(More)
  • 1